Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Beginning Cash Balance (2023 - 2025)

Historic Beginning Cash Balance for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to $850000.0.

  • BioScience Health Innovations' Beginning Cash Balance rose 23304.6% to $850000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 15153.2%. This contributed to the annual value of $1.1 million for FY2024, which is 8728.01% up from last year.
  • BioScience Health Innovations' Beginning Cash Balance amounted to $850000.0 in Q3 2025, which was up 23304.6% from $800000.0 recorded in Q2 2025.
  • Over the past 5 years, BioScience Health Innovations' Beginning Cash Balance peaked at $850000.0 during Q3 2025, and registered a low of $17952.0 during Q1 2023.
  • In the last 3 years, BioScience Health Innovations' Beginning Cash Balance had a median value of $255220.0 in 2024 and averaged $346906.8.
  • Data for BioScience Health Innovations' Beginning Cash Balance shows a peak YoY increase of 149369.43% (in 2024) and a maximum YoY decrease of 1895.6% (in 2024) over the last 5 years.
  • BioScience Health Innovations' Beginning Cash Balance (Quarter) stood at $248093.0 in 2023, then soared by 31.6% to $326500.0 in 2024, then skyrocketed by 160.34% to $850000.0 in 2025.
  • Its Beginning Cash Balance stands at $850000.0 for Q3 2025, versus $800000.0 for Q2 2025 and $522000.0 for Q1 2025.